Jithin Sam Varghese

Jithin Sam Varghese

Auto-generated profile, based on publicly available information

Jithin Sam Varghese

Emory University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2023 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JVJithin Sam Varghese
Jithin Sam Varghese
NVNikhil Srinivasapura Venkateshmurthy
Nikhil Srinivasapura Venkateshmurthy
NSNikkil Sudharsanan
Nikkil Sudharsanan
PJPanniyammakal Jeemon
Panniyammakal Jeemon
SPShivani A. Patel
Shivani A. Patel
MAMohammed K. Ali
Mohammed K. Ali
Hypertension is associated with 12.8% of all deaths globally.1 Many countries have implemented large-scale programs to diagnose and manage hypertension and other chronic diseases, with varying success.2,3 Of more than 1.3 billion people with hypertension globally, 82% live in low- and middle-income countries, and India alone is home to an estimated 220 million adults with hypertension.4-6 To address the burden of noncommunicable diseases, India launched the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke in 2010 (now known as the National Programme for Prevention and Control of Non-Communicable Diseases) under the National Health Mission for 100 districts across 21 states.7 However, few data are currently available to assess the success of and opportunities for improved control of high blood pressure at subnational levels.8

30 January 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JVJithin Sam Varghese
Jithin Sam Varghese
SSSumathi Swaminathan
Sumathi Swaminathan
AKAnura V. Kurpad
Anura V. Kurpad
TTTinku Thomas
Tinku Thomas
Anaemia prevalence in pregnant women of India declined from 57.9% to 50.3% from National Family Health Survey (NFHS)-3 to NFHS-4. However, over the course of that decade, the uptake of iron and folic acid (IFA) supplementation for 100 days of pregnancy improved by only 15%. To understand demand side risk factors of anaemia specifically related to IFA intake, an in-depth survey was conducted on pregnant women (n = 436) in 50 villages and wards of Sirohi district of Rajasthan, India. At the demand side, consistent IFA consumption in the previous trimester was inversely and strongly associated with anaemia (OR: 0.26, 95% CI: 0.12, 0.55). Reasons for inconsistent consumption included not registering to antenatal clinic, not receiving IFA tablets from the health worker and perceived lack of need. At the supply side, an analysis of IFA stock data at various levels of the health care (n = 168) providers from primary to tertiary levels showed that 14 out of 52 villages surveyed did not have access to IFA tablets. The closest availability of an IFA tablet for 16 villages, was more than 5 km away. To improve the uptake of IFA supplementation and thereby reduce iron deficiency anaemia in pregnant women, a constant supply of IFA at the village or sub-centre level, where frontline workers can promote uptake, should be ensured.

1 May 2019 in The Journal of Nutrition
Verified
Journal Article
Closed access
SSSumathi Swaminathan
Sumathi Swaminathan
Santu GhoshSantu Ghosh
Santu Ghosh
JVJithin Sam Varghese
Jithin Sam Varghese
HSHarshpal Singh Sachdev
Harshpal Singh Sachdev
AKAnura V Kurpad
Anura V Kurpad
TTTinku Thomas
Tinku Thomas
Anemia prevalence in India remains high despite preventive iron supplementation programs. Consequently, concurrent national policies of iron fortification of staple foods have been initiated. This study evaluated the relation between dietary iron intake and anemia (hemoglobin <12 g/dL) in women of reproductive age (WRA; 15-49 y) with respect to iron fortification in India. Data from 2 national surveys were used. Data on hemoglobin in WRA were sourced from the National Family Health Survey-4, whereas dietary intakes were sourced from the National Sample Survey. Adjusted odds for anemia with increasing iron intake were estimated, along with the effect of modulating nutrients such as vitamins B-12 and C, from statistically matched household data from the 2 surveys. The risks of inadequate (less than the Estimated Average Requirement for WRA) and excess (more than the tolerable upper limit for WRA) intakes of iron were estimated by the probability approach. The relation between iron intake and the odds of anemia was weak (OR: 0.992; 95% CI: 0.991, 0.994); increasing iron intake by 10 mg/d reduced the odds of anemia by 8%. Phytate and vitamin B-12 and C intakes modified this relation by reducing the odds by 1.5% when vitamin B-12 and C intakes were set at 2 μg/d and 40 mg/d, respectively. The additional intake of 10 mg/d of fortified iron reduced the risk of dietary iron inadequacy from 24-94% to 9-39% across states, with no risk of excess iron intake. Approximately doubling this additional iron intake reduced the risk of inadequacy to 2-12%, but the risk of excess intake reached 22%. Providing fortified iron alone may not result in substantial anemia reduction among WRA in India and could have variable benefits and risks across states. Geographically nuanced dietary strategies that include limited fortification and the intake of other beneficial nutrients should be carefully considered.

1 April 2019 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
JVJithin Sam Varghese
Jithin Sam Varghese
ASAryeh D Stein
Aryeh D Stein
In India, the prevalences of stunting and anemia have declined in the last decade, but continue to remain high in many regions, whereas those of overweight and obesity have increased in all age and socioeconomic groups. Determining whether these forms of malnutrition cluster is important for the development of appropriate interventions. Our objective was to describe the prevalence of a comprehensive list of dual burdens of malnutrition in individuals and households across the 36 states and 640 districts of India. We analyzed data from the National Family Health Survey-4, 2015-2016, including 655,156 women aged 15-49 y and 145,653 children aged 6-59 mo in India. We measured the coexistence of 19 combinations of women's anemia, underweight, and overweight and children's stunting, underweight, overweight, and anemia at the individual and household levels. We aggregated this information to the state (n = 36) and district (n = 640) levels. We examined whether the observed dual burden prevalence exceeded the expected prevalence, and whether any such excess was related to household wealth. Of the 19 dual burdens examined, 8 had significant excess prevalence at the state level and 5 had significant excess prevalence at the district level. All but 1 of these instances reflected an excess dual burden of undernutrition as opposed to clustering of overweight with a form of undernutrition. Household wealth was not positively associated with any clustering of burdens. While dual burdens of anemia, stunting, and underweight are prevalent, there is no evidence of clustering of overweight with other forms of malnutrition in India.

22 September 2022 in Primary Care Diabetes
Verified
Journal Article
Closed access
JVJithin Sam Varghese
Jithin Sam Varghese
KNK.M. Venkat Narayan
K.M. Venkat Narayan

4 August 2021 in Diabetes Technology & Therapeutics
Verified
Journal Article
Closed access
JVJithin Sam Varghese
Jithin Sam Varghese
JHJoyce C. Ho
Joyce C. Ho
RARanjit Mohan Anjana
Ranjit Mohan Anjana
RPRajendra Pradeepa
Rajendra Pradeepa
SPShivani A. Patel
Shivani A. Patel
VMViswanathan Mohan
Viswanathan Mohan
Aims: To identify profiles of type 2 diabetes from continuous glucose monitoring (CGM) data using ambulatory glucose profile (AGP) indicators and examine the association with prevalent complications. Methods: Two weeks of CGM data, collected between 2015 and 2019, from 5901 adult type 2 diabetes patients were retrieved from a clinical database in Chennai, India. Non-negative matrix factorization was used to identify profiles as per AGP indicators. The association of profiles with existing complications was examined using multinomial and logistic regressions adjusted for glycated hemoglobin (HbA1c; %), sex, age at onset, and duration of diabetes. Results: Three profiles of glycemic variability (GV) were identified based on CGM data—Profile 1 [“TIR Profile”] ( n = 2271), Profile 2 [“Hypo”] ( n = 1471), and Profile 3 [“Hyper”] ( n = 2159). Compared with time in range (TIR) profile, those belonging to Hyper had higher mean fasting plasma glucose (202.9 vs. 167.1, mg/dL), 2-h postprandial plasma glucose (302.1 vs. 255.6, mg/dL), and HbA1c (9.7 vs. 8.6; %). Both “Hypo profile” and “Hyper profile” had higher odds of nonproliferative diabetic retinopathy (“Hypo”: 1.44, 1.20–1.73; “Hyper”: 1.33, 1.11–1.58), macroalbuminuria (“Hypo”: 1.58, 1.25–1.98; “Hyper”: 1.37, 1.10–1.71), and diabetic kidney disease (DKD; “Hypo”: 1.65, 1.18–2.31; “Hyper”: 1.88, 1.37–2.58), compared with “TIR profile.” Those in “Hypo profile” (vs. “TIR profile”) had higher odds of proliferative diabetic retinopathy (PDR; 2.84, 1.65–2.88). Conclusions: We have identified three profiles of GV from CGM data. While both “Hypo profile” and “Hyper profile” had higher odds of prevalent DKD compared with “TIR profile,” “Hypo profile” had higher odds of PDR. Our study emphasizes the clinical importance of recognizing and treating hypoglycemia (which is often unrecognized without CGM) in patients with type 2 Diabetes Mellitus.